~~<i id='2619BEF453'><strike id='2619BEF453'><tt id='2619BEF453'><pre id='2619BEF453'></pre></tt></strike></i>~~

Home» explore» Wikipedia

Wikipedia

author：hotspot 2025-10-01 19:59:46 Page View：955

CMS Administrator Chiquita Brooks-LaSure Chip Somodevilla/Getty Images

WASHINGTON — Eli Lilly’s latest anti-amyloid Alzheimer’s treatment seems to slow the disease, the company announced this week — news that adds even more pressure on Medicare’s unprecedented restrictions on coverage.

Medicare has so far held firm on its plans to require patient registries for the entire class of anti-amyloid Alzheimer’s drugs, even after they are fully approved.

Pharmaceutical groups and patient advocates are increasingly fighting that approach.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Biden administration sends mixed signals on US soldier who crossed into North Korea
Next article： Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

leisure time

Hepatitis C has a cure — but many Americans still lack access to it

AdobeIn2005,NickVoyleswasdiagnosedwithhepatitisCafterbeingreleasedfromfiveyearsofincarceration.Anurs

Johnson & Johnson sues to stop Medicare negotiation

MARKRALSTON/AFPviaGettyImagesWASHINGTON— PharmaceuticalgiantJohnson&JohnsononTuesdaybecamethethi

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

FILE-Abortion-rightsprotestersfillIndianaStatehousecorridorsandcheeroutsidelegislativechambers,Frida

Lack of darker skin in textbooks, journals harms patients of color

HyacinthEmpinado/STATWhendermatologistJennaLesterlearnedthatrashesonskinandtoeswereasymptomofCovid-1